(Q24304329)

GOA release 2020-03-11

innate immune response

1 reference

GOA release 2020-03-11

hepatitis delta virus

object named as

hepatitis delta virus

1 reference

D Hartwig

1

0 references

C Schütte

2

0 references

J Warnecke

3

0 references

I Dorn

4

0 references

H Hennig

5

0 references

H Kirchner

6

0 references

P Schlenke

Journal of Viral Hepatitis

7

0 references

language of work or name

English

0 references

publication date

March 2006

0 references

published in

0 references

volume

13

0 references

issue

3

0 references

page(s)

150-7

0 references

cites work

By inhibiting replication, the large hepatitis delta antigen can indirectly regulate amber/W editing and its own expression

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2005.00663.X

Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression.

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2005.00663.X

Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2005.00663.X

Antiviral actions of interferons

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2005.00663.X

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

20 April 2017

1 reference

https://api.crossref.org/works/10.1111/J.1365-2893.2005.00663.X

Structure, sequence and expression of the hepatitis delta (delta) viral genome

20 April 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

The molecular biology of hepatitis delta virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

Antigens of hepatitis delta virus in the liver and serum of humans and animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

Human RNA-specific adenosine deaminase (ADAR1) gene specifies transcripts that initiate from a constitutively active alternative promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

Elevated activity of the large form of ADAR1 in vivo: Very efficient RNA editing occurs in the cytoplasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

Biased (A-->I) hypermutation of animal RNA virus genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

Interferon-alpha stimulation of liver cells enhances hepatitis delta virus RNA editing in early infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

Requirements for editing in the genomic RNA of hepatitis delta virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

Genomic but not antigenomic hepatitis delta virus RNA is preferentially exported from the nucleus immediately after synthesis and processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

Hepatic expression of interferon-alpha in chronic hepatitis B virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

Treatment of hepatitis D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

Cellular localization of alpha-interferon in hepatitis B virus-infected liver tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

7 January 2021

Ultrastructural localization of interferon-producing cells in the livers of patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

7 January 2021

delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

7 January 2021

A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

7 January 2021

A specific base transition occurs on replicating hepatitis delta virus RNA

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

7 January 2021

Assembly of hepatitis delta virus particles

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2005.00663.X

7 January 2021